Inventor Dean Kamen, National Coordinator for Health Information Technology Dr. Farzad Mostashari and Allscripts CEO Glen Tullman to Keynote Conference
NASHVILLE, Tenn., Aug. 29, 2011 /PRNewswire/ -- Allscripts (NASDAQ: MDRX) today launched its annual conference, the Allscripts Client Experience (ACE), with over 450 educational sessions for more than 4,700 attendees representing care providers in all settings, sizes and specialties.
"This year at ACE, many of the nation's leading healthcare organizations will showcase the next stage of health information technology, where insights provided by Electronic Health Records will begin to deliver measureable, broad-scale improvements in health outcomes," said Allscripts Chief Executive Officer Glen Tullman. "ACE gives our clients the opportunity to network, learn from client conducted education sessions, and hear first-hand about the successes of some of the most innovative healthcare organizations in the nation. Together, we're leveraging technology to improve the safety, coordination and efficiency of patient care."
Mr. Tullman will open the conference on Monday in a keynote focused on the next chapter in healthcare IT innovation, "Insights to Outcomes" or i2O. The approach is previewed in an editorial by Mr. Tullman yesterday in Healthcare IT News. Additionally, Allscripts today is posting 100 examples of leading healthcare organizations that are leveraging the i2O concept, producing insights that are driving significant improvements in health outcomes. To view their outcomes, go to www.allscripts.com/i2O.
Dr. Farzad Mostashari, National Health Information Technology Coordinator, will join Mr. Tullman onstage to discuss the ONC's perspective on the future of healthcare. The keynote will be streamed live on the Web beginning at 8 a.m. Central Time today. Click here to view the webcast, or visit www.allscripts.com/ace2011.
During Mr. Tullman's keynote, attendees will also see caregivers at Jefferson Regional Medical Center in Pine Bluff, Ark. sharing patient information between Allscripts Enterprise™ Electronic Health Record (EHR) in a physician practice, and Sunrise Clinical Manager™ in the hospital.
This demonstration of the live integration between the Company's ambulatory and acute care EHRs comes on the first anniversary of the merger of Allscripts and Eclipsys. To view a video of the integration go to: www.youtube.com/watch?v=N6wq7xifOUI.
On Tuesday, the keynote presenter is serial inventor Dean Kamen who will discuss innovation and how he earned over 400 patents, including breakthroughs in healthcare such as the first wearable insulin pump, and lifestyle innovations like the Segway® personal transport system.
Innovations for iPad®
In addition to demonstrating several soon-to-be-released solutions for the acute and ambulatory markets at ACE, Allscripts will demonstrate iPad apps that extend the usability of its Electronic Health Record platform for both physician practices and hospitals.
For hospitals, Sunrise Mobile MD™ II maximizes the capabilities of iPad®, giving physicians intuitive mobile access to vital clinical information about their hospitalized patients. The solution is especially designed to support the mobile activity of patient rounding by enabling physicians to view and find patient summaries, place orders, create progress notes, review and forward documents as well as capture charges.
Sunrise Mobile MD II can be downloaded on the App Store for any iPhone or iPad: http://bit.ly/oyEpiR.
For multi-media images of Sunrise Mobile MD II, please email a request to Allscripts Public Relations.
Allscripts (NASDAQ: MDRX) provides innovative solutions that empower all stakeholders across the healthcare continuum to deliver world-class outcomes. The company's Electronic Health Record, Computerized Physician Order Entry and other clinical, financial, connectivity and information solutions for hospitals, physicians and post-acute organizations are the essential technologies that enable a Connected Community of Health™. To learn more about Allscripts, please visit www.allscripts.com, Twitter, Facebook and YouTube.
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that the expected synergies, efficiencies and cost savings of the merger with Eclipsys Corporation ("Eclipsys") will not be realized, or will not be realized within the expected time period; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that the Allscripts and Eclipsys businesses will not be integrated successfully; competition within the industries in which we operate; failure to achieve certification under the Health Information Technology for Economic and Clinical Health Act could result in increased development costs, a breach of some customer obligations and could put us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; the outcome of any legal proceeding that has been or may be instituted against us; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; and breach of our security by third parties. See our Annual Report on Form 10-KT for the seven months ended December 31, 2010 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.
SOURCE Allscripts Healthcare Solutions, Inc.